Darah Protas

Partner
Full contact info

Experience

Silvaco Announces $114 Million IPO

May 13, 2024

Cooley advised the underwriters of Silvaco, a leading provider of technology computer-aided design (TCAD), electronic design animation (EDA) software, and session initiation protocol (SIP) solutions that enable semiconductor design and artificial intelligence through software and innovation, on its $114 million initial public offering.

Read more

Related contacts

Eric Jensen
Vice Chair, Palo Alto
Richard Segal
Partner, New York
Darah Protas
Partner, Washington, DC
Kevin King
Partner, Washington, DC
Mark Lambert
Partner, Palo Alto
Eileen Marshall
Partner, Washington, DC
Alessandra Murata
Partner, Palo Alto
Nyron J. Persaud
Partner, New York
Scott Weston
Partner, Boston
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Kassity L. Mai
Special Counsel, Reston
Kimberly Nguyen
Special Counsel, Reston
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Peter Burns
Of Counsel, Palo Alto
Mor Agam
Associate, New York
Anitha Anne
Associate, San Francisco
Chris Chynoweth
Associate, New York
Megan Drill
Associate, San Diego
Katherine King
Associate, Washington, DC
Allison Kutner
Associate, New York
Evan Leitner
Associate, New York
Kristin R. Marshall
Associate, Washington, DC
Greg Merchant
Associate, Palo Alto
Anisha Mohin
Associate, New York
Charles York
Associate, New York
Margie Murphy
Paralegal Specialist, New York

Related Practices & Industries

Immunology Company argenx Announces $1.27 Billion Global Offering

July 26, 2023

Cooley advised J.P. Morgan, Morgan Stanley, Goldman Sachs, BofA Securities and TD Cowen, representatives of the several underwriters, in the $1.27 billion follow-on offering by argenx SE, a global immunology company.

Read more

Related contacts

Richard Segal
Partner, New York
Div Gupta
Partner, New York
Darah Protas
Partner, Washington, DC
Charles York
Associate, New York
Katie Lapidus
Associate, Washington, DC
Bill Christiansen
Partner, Seattle
Phil Mitchell
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Dr. Tian Yong Zheng
Patent Agent, Seattle

Related Practices & Industries

Apogee Therapeutics Announces Upsized $345.1 Million IPO

July 18, 2023

Cooley advised the underwriters in the upsized $345.1 million initial public offering of Apogee Therapeutics, a biotechnology company.

Read more

Related contacts

Charlie Kim
Partner, San Diego
Div Gupta
Partner, New York
Kristin VanderPas
Partner, San Francisco
Madhuri Roy
Partner, Palo Alto
Stephanie Gentile
Partner, New York
Geoffrey Spolyar
Partner, Boston
Phil Mitchell
Partner, New York
Francis Wheeler
Partner, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Randy Sabett
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Madison (JJ) Meng
Associate, San Francisco
Megan Drill
Associate, San Diego
Alessandra Murata
Partner, Palo Alto
Darah Protas
Partner, Washington, DC
Mike Lam
Associate, Santa Monica
David Dalton
Associate, Santa Monica
Peter A. Haddad
Associate, San Diego

Related Practices & Industries

Prelude Therapeutics – $100 Million Follow-on Offering

May 18, 2023

Cooley advised the underwriters in Prelude Therapeutics’ $100 million follow-on offering. Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways. Lawyers Richard Segal, Div Gupta, Darah Protas, Sam Paullin and Katie Lapidus led the Cooley team.

Related contacts

Richard Segal
Partner, New York
Virat Gupta
Associate, Washington, DC
Darah Protas
Partner, Washington, DC
Samuel Paullin
Associate, Chicago
Katie Lapidus
Associate, Washington, DC

Related Practices & Industries

Karuna Therapeutics – $460 Million Follow-on Offering

March 21, 2023

Cooley advised the underwriters in Karuna Therapeutics’ $460 million follow-on offering. Karuna is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. Goldman Sachs & Co., JP Morgan, Morgan Stanley, Stifel, and Guggenheim Securities acted as joint book-running managers for the offering. Partners Richard Segal, Div Gupta and Jean Park led the Cooley team.

Related contacts

Richard Segal
Partner, New York
Div Gupta
Partner, New York
Jean Park
Partner, New York
Darah Protas
Partner, Washington, DC
Katie Lapidus
Associate, Washington, DC
Charles York
Associate, New York

Related Practices & Industries

View more

Admissions and credentials

District of Columbia